Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling.

Abstract:

:In the last three decades, protein and nucleic acid structure determination and comprehension of the mechanisms, leading to their physiological and pathological functions, have become a cornerstone of biomedical sciences. A deep understanding of the principles governing the fates of cells and tissue at the molecular level has been gained over the years, offering a solid basis for the rational design of drugs aimed at the pharmacological treatment of numerous diseases. Historically, affinity indicators (i.e. Kd and IC50/EC50) have been assumed to be valid indicators of the in vivo efficacy of a drug. However, recent studies pointed out that the kinetics of the drug-receptor binding process could be as important or even more important than affinity in determining the drug efficacy. This eventually led to a growing interest in the characterisation and prediction of the rate constants of protein-ligand association and dissociation. For instance, a drug with a longer residence time can kinetically select a given receptor over another, even if the affinity for both receptors is comparable, thus increasing its therapeutic index. Therefore, understanding the molecular features underlying binding and unbinding processes is of central interest towards the rational control of drug binding kinetics. In this review, we report the theoretical framework behind protein-ligand association and highlight the latest advances in the experimental and computational approaches exploited to investigate the binding kinetics.

journal_name

Medchemcomm

journal_title

MedChemComm

authors

Bernetti M,Cavalli A,Mollica L

doi

10.1039/c6md00581k

subject

Has Abstract

pub_date

2017-01-30 00:00:00

pages

534-550

issue

3

eissn

2040-2503

issn

2040-2511

pii

c6md00581k

journal_volume

8

pub_type

杂志文章,评审
  • Developing novel C-4 analogues of pyrrole-based antitubulin agents: weak but critical hydrogen bonding in the colchicine site.

    abstract::The synthesis, biological evaluation and molecular modeling of a series of pyrrole compounds related to 3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid that evaluates and optimizes C-4 substituents are reported. The key factor for microtubule depolymerization activity appears to be the presence of an ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C2MD20320K

    authors: Da C,Telang N,Hall K,Kluball E,Barelli P,Finzel K,Jia X,Gupton JT,Mooberry SL,Kellogg GE

    更新日期:2013-01-01 00:00:00

  • Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception.

    abstract::It was previously reported that 6β-aminomorphinan derivatives show high affinity for opiate receptors. Novel 6β-heteroarylamidomorphinanes were designed based on the MOR selective antagonist NAP. The 6β-aminomorphinanes were prepared with stereoselective Mitsunobu reaction and subsequently acylated with nicotinic acid...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C6MD00450D

    authors: Urai Á,Váradi A,Szőcs L,Komjáti B,Le Rouzic V,Hunkele A,Pasternak GW,Majumdar S,Hosztafi S

    更新日期:2017-01-01 00:00:00

  • Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method.

    abstract::Many reports have suggested that NRP-1 acts as a co-receptor for VEGF-A165 and boosts tumour growth and metastasis. This NRP-1, due to its important role in tumour progression, triggered interest in the design of new molecules able to significantly inhibit NRP-1/VEGF-A165 interaction to suppress pathological angiogene...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00537k

    authors: Puszko AK,Sosnowski P,Tymecka D,Raynaud F,Hermine O,Lepelletier Y,Misicka A

    更新日期:2019-01-25 00:00:00

  • A zwitterionic near-infrared dye linked TrkC targeting agent for imaging metastatic breast cancer.

    abstract::Much effort has been devoted to targeting agents for imaging and chemotherapy of tumors in cancer research, but there remain significant unmet needs in that area. We have reported a series of preclinical TrkC targeting agents for diagnoses and treatment of metastatic breast cancer; however, with respect to optical ima...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00190a

    authors: Yang Z,Usama SM,Li F,Burgess K,Li Z

    更新日期:2018-08-03 00:00:00

  • Targeting the trehalose utilization pathways of Mycobacterium tuberculosis.

    abstract::Tuberculosis (TB) is an epidemic disease and the growing burden of multidrug-resistant (MDR) TB world wide underlines the need to discover new drugs to treat the disease. Mycobacterium tuberculosis (Mtb) is the etiological agent of most cases of TB. Mtb is difficult to treat, in part, due to the presence of a sturdy h...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C5MD00376H

    authors: Thanna S,Sucheck SJ

    更新日期:2016-01-01 00:00:00

  • Cu(ii), Ga(iii) and In(iii) complexes of 2-acetylpyridine N(4)-phenylthiosemicarbazone: synthesis, spectral characterization and biological activities.

    abstract::In this paper, synthesis and characterization of metal complexes [Cu2(L)3]ClO4 (1), [Ga(L)2]NO3·2H2O (2) and [In(L)2]NO3·H2O (3) (HL = 2-acetylpyridine N(4)-phenylthiosemicarbazone) was carried out, including elemental analysis, spectral analysis (IR, UV-vis, NMR), and X-ray crystallography. Complex 1 contains one S-b...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c7md00415j

    authors: Wang YT,Fang Y,Zhao M,Li MX,Ji YM,Han QX

    更新日期:2017-10-09 00:00:00

  • Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class.

    abstract::Diabetes mellitus is a chronic, complex and multifactorial disease associated characteristically with hyperglycemia. One of the most recently approved antidiabetic drug classes for clinical use are sodium-glucose cotransporter type 2 (SGLT-2) inhibitors. SGLT-2 is a protein expressed in the kidneys, responsible for gl...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c8md00183a

    authors: da Silva PN,da Conceição RA,do Couto Maia R,de Castro Barbosa ML

    更新日期:2018-06-06 00:00:00

  • Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors.

    abstract::N-Acylethanolamine acid amidase (NAAA) is one of the key enzymes involved in the degradation of fatty acid ethanolamides (FAEs), especially for palmitoylethanolamide (PEA). Pharmacological blockage of NAAA restores PEA levels, providing therapeutic benefits in the management of inflammation and pain. In the current wo...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00432c

    authors: Zhou P,Xiang L,Zhao D,Ren J,Qiu Y,Li Y

    更新日期:2018-12-18 00:00:00

  • Microwave-enhanced Friedländer synthesis for the rapid assembly of halogenated quinolines with antibacterial and biofilm eradication activities against drug resistant and tolerant bacteria.

    abstract::Herein, we disclose the development of a catalyst- and protecting-group-free microwave-enhanced Friedländer synthesis which permits the single-step, convergent assembly of diverse 8-hydroxyquinolines with greatly improved reaction yields over traditional oil bath heating (increased from 34% to 72%). This rapid synthes...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00381h

    authors: Garrison AT,Abouelhassan Y,Yang H,Yousaf HH,Nguyen TJ,Huigens Iii RW

    更新日期:2016-07-27 00:00:00

  • Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance().

    abstract::A series of cyclic peptides were designed and prepared to investigate the physicochemical properties that affect oral bioavailabilty of this chemotype in rats. In particular, the ionization state of the peptide was examined by the incorporation of naturally occurring amino acid residues that are charged in differing r...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C2MD20203D

    authors: Rand AC,Leung SS,Eng H,Rotter CJ,Sharma R,Kalgutkar AS,Zhang Y,Varma MV,Farley KA,Khunte B,Limberakis C,Price DA,Liras S,Mathiowetz AM,Jacobson MP,Lokey RS

    更新日期:2012-10-01 00:00:00

  • Synthesis and biological activity evaluation of novel peroxo-bridged derivatives as potential anti-hepatitis B virus agents.

    abstract::Previous studies have demonstrated that natural steroid compounds containing a peroxide bridge exhibited potential anti-hepatitis B virus activity. To continue our research, a simple and regioselective methodology, using Eosin Y as a clean photosensitized oxidation catalyst, was developed for the synthesis of a peroxi...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00344c

    authors: Jia M,Zhao R,Xu B,Yan W,Chu F,Gu H,Xie T,Xiang H,Ren J,Chen D,Wang P,Lei H

    更新日期:2016-10-19 00:00:00

  • Biochemical and microbiological evaluation of N-aryl urea derivatives against mycobacteria and mycobacterial hydrolases.

    abstract::A focused library of 24 N-aryl urea derivatives was prepared and evaluated against serine esterases of Mycobacterium tuberculosis (Mtb) Rv3802c and Mtb Ag85C. The members of the library were evaluated for both selectivity and mode of inhibition. Furan-based urea derivative 6c was found to be the most potent non-covale...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00122k

    authors: Vartak A,Goins C,de Moura VCN,Schreidah CM,Landgraf AD,Lin B,Du J,Jackson M,Ronning DR,Sucheck SJ

    更新日期:2019-06-04 00:00:00

  • Adaptive mechanisms of resistance to anti-neoplastic agents.

    abstract::Intrinsic and acquired resistance to conventional and targeted therapeutics is a fundamental reason for treatment failure in many cancer patients. Targeted approaches to overcome chemoresistance as well as resistance to targeted approaches require in depth understanding of the underlying molecular mechanisms. The anti...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c6md00394j

    authors: Ferreira BI,Lie MK,Engelsen AST,Machado S,Link W,Lorens JB

    更新日期:2016-10-21 00:00:00

  • Diazabicyclo analogues of maraviroc: synthesis, modeling, NMR studies and antiviral activity.

    abstract::Two diazabicyclo analogues of maraviroc, in which the azabicyclooctane moiety is replaced by diazabicyclooctane or diazabicyclononane, were synthesized and tested, through a viral neutralization assay, on a panel of six pseudoviruses. The diazabicyclooctane derivative maintained a significant infectivity reduction pow...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00575f

    authors: Legnani L,Colombo D,Venuti A,Pastori C,Lopalco L,Toma L,Mori M,Grazioso G,Villa S

    更新日期:2016-12-16 00:00:00

  • Development of a peptide-based bifunctional chelator conjugated to a cytotoxic drug for the treatment of melanotic melanoma.

    abstract::The cytotoxic drug gemcitabine (GEM) has been conjugated to receptor-binding peptides to target melanoma tumors. A hexapeptide having a Lys-Gly-His-Lys sequence (pep-1), an octapeptide with an Arg-Gly-Asp-Lys-Gly-His-Lys sequence (pep-2), a GEM-conjugated Lys-Gly-His-Lys peptide (GEM-pep-3) and a GEM-conjugated Asp-Gl...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c7md00638a

    authors: Gaonkar RH,Baishya R,Paul B,Dewanjee S,Ganguly S,Debnath MC,Ganguly S

    更新日期:2018-03-06 00:00:00

  • Novel lead compounds in pre-clinical development against African sleeping sickness.

    abstract::Human African trypanosomiasis (HAT), also known as African sleeping sickness, is caused by parasitic protozoa of the genus Trypanosoma. As the disease progresses, the parasites cross the blood brain barrier and are lethal for the patients if the disease is left untreated. Current therapies suffer from several drawback...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c7md00280g

    authors: Berninger M,Schmidt I,Ponte-Sucre A,Holzgrabe U

    更新日期:2017-07-31 00:00:00

  • Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists.

    abstract::The dopamine D3 receptor (D3R) is a proven therapeutic target for the treatment of neurological and neuropsychiatric disorders. In particular, D3R-selective ligands that can eliminate side effects associated with dopamine D2 receptor (D2R) therapeutics have been validated. However, the high homology in signaling pathw...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00237a

    authors: Cao Y,Sun N,Zhang J,Liu Z,Tang YZ,Wu Z,Kim KM,Cheon SH

    更新日期:2018-06-14 00:00:00

  • Repositioning Salirasib as a new antimalarial agent.

    abstract::Malaria is a serious tropical disease that kills thousands of people every year, mainly in Africa, due to Plasmodium falciparum infections. Salirasib is a promising cancer drug candidate that interferes with the post-translational modification of Ras. This S-farnesyl thiosalicylate inhibits isoprenylcysteine carboxyl ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00298g

    authors: Porta EOJ,Bofill Verdaguer I,Perez C,Banchio C,Ferreira de Azevedo M,Katzin AM,Labadie GR

    更新日期:2019-06-21 00:00:00

  • Correction: Recent updates in the discovery and development of novel antimalarial drug candidates.

    abstract::[This corrects the article DOI: 10.1039/C7MD00637C.]. ...

    journal_title:MedChemComm

    pub_type: 杂志文章,已发布勘误

    doi:10.1039/c8md90009d

    authors: Okombo J,Chibale K

    更新日期:2018-03-02 00:00:00

  • Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A3 adenosine receptor antagonists.

    abstract::Recognition of nucleosides at adenosine receptors (ARs) is supported by multiple X-ray structures, but the structure of an adenine complex is unknown. We examined the selectivity of predicted A1AR and A3AR adenine antagonists that incorporated known agonist affinity-enhancing N6 and C2 substituents. Adenines with A1AR...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00317c

    authors: Yu J,Mannes P,Jung YH,Ciancetta A,Bitant A,Lieberman DI,Khaznadar S,Auchampach JA,Gao ZG,Jacobson KA

    更新日期:2018-10-18 00:00:00

  • Discovery of a tetrazolyl β-carboline with in vitro and in vivo osteoprotective activity under estrogen-deficient conditions.

    abstract::β-Carbolines have been assessed for osteoclastogenesis. However, their effect on osteoblasts during estrogen deficiency is still unclear. Here, a series of novel piperazine and tetrazole tag β-carbolines have been synthesized and examined for osteoblast differentiation in vitro. In vitro data suggest that compound 8g ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00109j

    authors: Karvande A,Khan S,Khan I,Singh D,Khedgikar V,Kushwaha P,Ahmad N,Kothari P,Dhasmana A,Kant R,Trivedi R,Chauhan PMS

    更新日期:2018-06-12 00:00:00

  • On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome.

    abstract::The type III secretion system injectisome is a syringe-like multimembrane spanning nanomachine that is essential to the pathogenicity but not viability of many clinically relevant Gram-negative bacteria, such as enteropathogenic Escherichia coli, Salmonella enterica and Pseudomonas aeruginosa. Due to the rise in antib...

    journal_title:MedChemComm

    pub_type: 杂志文章,评审

    doi:10.1039/c9md00146h

    authors: Lyons BJE,Strynadka NCJ

    更新日期:2019-06-20 00:00:00

  • Hepatocellular targeted α-tocopherol based pH sensitive galactosylated lipids: design, synthesis and transfection studies.

    abstract::Receptor mediated gene delivery to the liver offers advantages in treating genetic disorders such as hemophilia and hereditary tyrosinemia type I (HTI). Prior findings demonstrated that tethering the d-galactose head group to cationic lipids directs genes to the liver via asialoglycoprotein receptors (ASGPRs). In our ...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c7md00503b

    authors: Muripiti V,Lohchania B,Marepally SK,Patri SV

    更新日期:2017-12-06 00:00:00

  • Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells.

    abstract::Sphingosine 1-phosphate (S1P) is involved in hyper-proliferative diseases such as cancer and pulmonary arterial hypertension. We have synthesized inhibitors that are selective for the two isoforms of sphingosine kinase (SK1 and SK2) that catalyze the synthesis of S1P. A thiourea adduct of sphinganine (F02) is selectiv...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C3MD00201B

    authors: Byun HS,Pyne S,Macritchie N,Pyne NJ,Bittman R

    更新日期:2013-01-01 00:00:00

  • Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.

    abstract::Previous studies on the large-scale glycomics of more than 3500 human serum samples revealed that the serum glycoproteins of cancer patients often have more dominant and specific glycoforms, namely, branched tri- and tetra-antennary N-glycans, most cancer patient groups than normal control groups. We herein establishe...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00162f

    authors: Yogesh KV,Kamiyama T,Ohyama C,Yoneyama T,Nouso K,Kimura S,Hinou H,Nishimura SI

    更新日期:2018-06-29 00:00:00

  • Synthesis and in vitro evaluation of substituted 3-cinnamoyl-4-hydroxy-pyran-2-one (CHP) in pursuit of new potential antituberculosis agents.

    abstract::Tuberculosis is an ever-evolving infectious disease that urgently needs new drugs. In the search for new antituberculosis agents, a library of 3-cinnamoyl-4-hydroxy-6-methyl-2H-pyran-2-ones (CHPs) (2a-2y) was synthesized and evaluated against a standard virulent laboratory strain of Mycobacterium tuberculosis H37Rv. O...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c7md00366h

    authors: Bhat ZS,Ul Lah H,Rather MA,Maqbool M,Ara T,Ahmad Z,Yousuf SK

    更新日期:2017-12-06 00:00:00

  • Structure-Based Design, Synthesis by Click Chemistry and in Vivo Activity of Highly Selective A3 Adenosine Receptor Agonists.

    abstract::2-Arylethynyl derivatives of (N)-methanocarba adenosine 5'-uronamides are selective A3AR (adenosine receptor) agonists. Here we substitute a 1,2,3-triazol-1-yl linker in place of the rigid, linear ethynyl group to eliminate its potential metabolic liability. Docking of nucleosides containing possible short linker moie...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/C4MD00571F

    authors: Tosh DK,Paoletta S,Chen Z,Crane S,Lloyd J,Gao ZG,Gizewski ET,Auchampach JA,Salvemini D,Jacobson KA

    更新日期:2015-01-01 00:00:00

  • Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents.

    abstract::The natural products colchicine and combretastatin A-4 (CA4) have provided inspiration for the discovery and development of a wide array of derivatives and analogues that inhibit tubulin polymerization through a binding interaction at the colchicine site on β-tubulin. A water-soluble phosphate prodrug salt of CA4 (ref...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c8md00322j

    authors: Maguire CJ,Chen Z,Mocharla VP,Sriram M,Strecker TE,Hamel E,Zhou H,Lopez R,Wang Y,Mason RP,Chaplin DJ,Trawick ML,Pinney KG

    更新日期:2018-08-24 00:00:00

  • High affinity rigidified AT2 receptor ligands with indane scaffolds.

    abstract::Rigidification of the isobutyl side chain of drug-like AT2 receptor agonists and antagonists that are structurally related to the first reported selective AT2 receptor agonist 1 (C21) delivered bioactive indane derivatives. Four enantiomer pairs were synthesized and the enantiomers were isolated in an optical purity >...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c9md00402e

    authors: Wallinder C,Sköld C,Sundholm S,Guimond MO,Yahiaoui S,Lindeberg G,Gallo-Payet N,Hallberg M,Alterman M

    更新日期:2019-11-18 00:00:00

  • Toxicity of tryptophan manganese(i) carbonyl (Trypto-CORM), against Neisseria gonorrhoeae.

    abstract::The potential for carbon monoxide-releasing molecules (CO-RMs) as antimicrobials represents an exciting prospective in the fight against antibiotic resistance. Trypto-CORM, a tryptophan-containing manganese(i) carbonyl, is toxic against E. coli following photo-activation. Here, we demonstrate that Trypto-CORM is toxic...

    journal_title:MedChemComm

    pub_type: 杂志文章

    doi:10.1039/c6md00603e

    authors: Ward JS,Morgan R,Lynam JM,Fairlamb IJS,Moir JWB

    更新日期:2016-12-06 00:00:00